drugset / Trial / NCT01103349

BI 671800 in Asthmatic Patients on Inhaled Corticosteroids

NCT01103349

Phase 2 Completed 243 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 6 week study to assess the effect of BI 671800 in patients with asthma. It is a double blind, parallel arm trial testing the safety and efficacy of BI 671800. The main objective is to assess the effect on lung function. The study will also provide data on the pharmacokinetics of BI 671800.

Timeline

Start
2010-04-20
Primary completion
2011-08-09
Completion
2011-08-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 671800 Small molecule Oral
Comparator Montelukast Other / unclassified

Indications